Market Overview
The
Global Ultrasonic Scalpels Market size is expected to reach a
value of USD 2,397.6 million in 2024, and it is further anticipated to reach a market
value of USD 5,089.1 million by 2033 at a
CAGR of 8.7%.
The ultrasonic scalpel market is defined and consists of the worldwide industry for developing, producing, marketing, and using innovative ultrasonic scalpel equipment for surgeries. These instruments use ultrasonication and cut, coagulate, and dissect the tissues required in surgeries. The market consists of ultrasonic scalpel systems, generators, handpiece accessories, and a wide range of specialty-specific products.
Their uses are extended to different surgeries such as orthopedic, gynecologic, ophthalmologic, urologic, cardiovascular, and other surgeries. The variety of these scalpels’ end-users also infuses the market, which includes hospitals, ambulatory surgery centers, as well as specialty clinics. Finally, it is so much about providing a market with better options to help patients and enable surgeons to use improved tools, and the changing scene shows that the subject is constantly evolving, as all kinds of medical advancements are in constant change and development.
The US Ultrasonic Scalpels Market
The US Ultrasonic Scalpels Market size is anticipated to hold USD 687.6 million of the total global market revenue and is further projected to show this market concentration as it is projected to hold USD 1,394.2 million in 2033 at a CAGR of 8.2%.
The ultrasonic scalpels market in the US is growing at a high rate due to factors such as an increased rate of chronic diseases and a surge in the number of surgical procedures. Ultrasonic scalpels are modern-day surgical implements that employ ultrasonic frequencies to sever tissue as well as clot blood, giving efficient surgical results.
- Technological development is also a factor in the market since these commodities have become safer and more effective. The increasing preference of people towards minimally invasive surgical procedures that have less postoperative morbidity and shorter recovery periods is also adding to the market growth. Also, the increase in global healthcare costs and the well-developed healthcare facilities in the US are other factors that are fueling the market growth.
- The market is also backed up by appropriate government policies and the growing consciousness of ultrasonic scalpels among healthcare specialists. However, high costs related to these devices and the need to have professional persons to operate these devices may act as challenges to the market.
Key Takeaways
- Market Value: This market size is expected to reach a value of USD 5,089.1 million by 2033 from the base value of USD 2,397.6 million in 2024 at a CAGR of 8.7%.
- By Product Segment Analysis: Ultrasonic scalpel systems are projected to dominate the product segment as they hold 53.8% of the market share in 2024.
- By Application Segment Analysis: Based on application, orthopedic surgery is expected to dominate this segment as it holds 32.2% of the market share in 2024.
- By End User Segment Analysis: Hospitals stand as the predominant end-users in the market for medical devices like ultrasonic scalpels in 2024 due to various reasons.
- Regional Analysis: North America is projected to dominate the global ultrasonic scalpels market as it holds 34.1% of the market share in 2024 and is projected to show subsequent growth in the upcoming period of 2024 to 2034.
Use Cases
- General Surgery: Ultrasonic scalpels are extensively utilized in popular surgeries for precise tissue dissection and coagulation, decreasing bleeding and improving surgical effects.
- Oncological Surgery: These scalpels are crucial in oncological procedures, offering precision in tumor elimination while minimizing harm to surrounding healthy tissues.
- Cardiovascular Surgery: Ultrasonic scalpels are utilized in cardiovascular surgical procedures for delicate tissue slicing and vessel sealing, improving the protection and efficacy of the methods.
- Gynecological Surgery: In gynecological procedures, ultrasonic scalpels offer unique slicing and coagulation, leading to reduced operative time and improved patient recovery.
Market Dynamic
Trends
Technological AdvancementsLeading manufacturers of ultrasonic scalpel products include Johnson & Johnson and Medtronic as they continue to develop innovative products in this market. A few of the developments are an energy delivery system and a newer ergonomic design that increases the arthroscopic surgical accuracy and decreases the amount of time required for surgery. For example, Harmonic Ace+7 produced by Johnson & Johnson enables precise dissection and highly effective coagulation which explains its use in different surgeries.
Rise in Minimally Invasive Surgeries
Most of the factors affecting the market are global and the rising popularity of minimally invasive surgeries (MIS) is one of the most prominent factors. Laparoscopic surgeries that are part of MIS procedures are being practiced frequently because of the privileges that come along with the practice like short hospital stays and early recovery. Ethicon, a Johnson & Johnson company, has an array of products such as ultrasonic scalpels that are in high demand in these procedures, thus escalating the market’s growth rate.
Growth Drivers
Increasing Prevalence of Chronic Diseases
With the advancement of age and an increase in the prevalence of conditions such as cancer or cardiovascular diseases, surgeries are needed. According to the American Cancer Society, there were approximately 1.9 million new cancer cases diagnosed in the US in 2023 alone. Only in the United States, it is predicted that in the year 2023, about 9 million new cancer cases shall have been diagnosed. This increase in the number of surgeries has the added effect of increasing the use of ultrasonic scalpels as they remove tumors with proper accuracy.
Growing Healthcare Expenditure
Healthcare Expenditure in the developed regions is on the rise; this has enhanced the ability to acquire and use better surgical tools. For instance, in India as well as China, healthcare spending has risen to bigger levels, whereby hospitals have been employing such elements as ultrasonic scalpels. Global sales have also expanded and Medtronic attributes that to; higher per capita and infrastructure on healthcare.
Growth Opportunities
Emerging Markets
There are vast opportunities that have not yet been explored in the different parts of the world like the South East Asia and Africa. Implementing the constantly increasing healthcare consciousness and progressing infrastructure, these markets are implementing advanced surgeries. For instance, the Olympics Corporation of Japan has been continuing to invest in the SEA region with the rising need for minimally invasive surgery instruments.
Strategic Collaborations
Establishing collaborations and partnerships with key stakeholders and healthcare organizations is crucial in the development of new products and gaining access to new customers. In 2023, Stryker Corporation collaborated with several hospitals in Europe to improve the training in surgical techniques using advanced technology, particularly the ultrasonic scalpel.
Restraints
High Costs
The ultrasonic scalpels and procedures involving their use are relatively expensive; thus, their usage may be restricted. In LMICs, there is usually less healthcare expenditure implying that hospitals may lean towards the cheaper perfumed products. For example, a report from Frost & Sullivan emphasized the high cost of ultrasonic scalpels as a key challenge in areas of Africa and Latin America.
Need for Skilled Professionals
The use of ultrasonic scalps entails the use of highly trained healthcare providers. The market is impaired by skilled personnel scarcity, something that affects developing countries in particular due to the scarce availability of skilled personnel. A study carried out by the World Health Organization revealed that in many developing nations, there is a shortage of trained surgeons which will affect the use of sophisticated surgical equipment.
Research Scope and Analysis
By Product
In terms of product, Ultrasonic scalpel systems take center stage in the product segment as they hold 53.8% of the market share in 2024. This dominance is due to their integrated cutting and coagulation functionalities, which offer surgeons a seamless transition between modes during procedures. The systems enhance precision and control, optimizing energy delivery for efficient tissue cutting with minimal thermal damage. User-friendly operation, compatibility with various accessories, and reduced instrument clutter contribute to the appeal of these systems in the operating room.
Despite a potentially higher initial investment, the integrated nature of ultrasonic scalpel systems can result in long-term cost savings. Continuous technological advancements, coupled with their clinical versatility across diverse surgical applications, reinforce the dominance of ultrasonic scalpel systems in the market. This comprehensive and adaptable solution underscores their significance for surgeons and healthcare facilities seeking advanced technology with operational convenience.
By Application
Based on application, orthopedic surgery is projected to dominate this segment as it holds 32.2% of the market share in 2024 and is expected to show subsequent growth in the forthcoming g period of 2024 to 2033. Orthopedic surgery reappears as the chief market segment for ultrasonic scalpels based on several factors that dovetail with the specific attributes of orthopedic operations. Thanks to the high spatial resolution of ultrasonic scalpels in cutting bones and tissues and due to their reduced thermal effects, the use of ultrasonic scalpels can be especially useful in precise surgeries, which is the case in orthopedics.
Specifically useful in most minimally invasive surgeries, ultrasonic scalps improve control of the soft tissues; their application is diverse, from joint replacement to spine surgery, sports medicine, and trauma surgeries. They can also be used efficiently in bone dissection and bone modeling, moreover, they can offer adequate hemostasis, particularly in highly vascularized bone surgery therefore making them widely used. The overall effect regarding patients’ outcomes and recovery is consistent with the objectives of orthopedic surgery, which is to improve people’s mobility and, subsequently, their quality of living.
However, orthopedic surgery is a discipline that widely uses the ultrasonic scalpel, which also has other surgical specialties depending on specific procedural characteristics.
By End User
Hospitals are projected to stand as the predominant end-users in the market for medical devices like ultrasonic scalpels in 2024 due to various reasons. This is because ultrasonic scalpel-type surgical tools are highly versatile in their use in handling a wide variety of surgeries, this coupled with enhanced surgical endowments and specialized departments make hospitals the most suitable environments for the use of ultrasonic scalps.
Wholly-owned medical centers have a large pool of patients with which they can experiment with recent advancements in technologies because of the skilled nursing personnel and affiliations with university research institutions. Hospitals have full-fledged patient diagnostic and treatment facilities as their prime responsibility and avail the advantage of bulk purchasing to acquire efficient top-notch equipment at reasonable prices.
Although, hospitals predominantly use ultrasonic scalpels, ASC and specialty clinics also have their share, especially for specific operations and outpatient surgeries depending on given contextual factors including the nature of procedures, patients’ choice, and availability of equipment and resources in different healthcare facilities.
The Ultrasonic Scalpels Market Report is segmented based on the following
By Product
- Ultrasonic Scalpel System
- Ultrasonic Scalpel Accessories
- Ultrasonic Scalpel Generators
By Application
- Orthopedic Surgery
- Gynecological Surgery
- Ophthalmic Surgery
- Urological Surgery
- Cardiovascular Surgery
- Other
By End User
- Hospitals
- Ambulatory Surgery Centers
- Specialty Clinics
Regional Analysis
North America is projected to dominate the global ultrasonic scalpels market as it
holds 34.1% of the market share in 2024 and is projected to show subsequent growth in the upcoming period of 2024 to 2033. The region’s healthcare facilities are well developed especially in the United States in this regard and new technologies that crop up in the developed countries are quickly deployed.
The existence of a strong research and development culture, a partnership between industry and academic institutions, and strict compliance with higher regulatory guidelines which is evident from the exemplification from the FDA, of the Americas supports this observation. The foregoing analysis of the profit impact of ultrasonic scalpels indicates that the propensity of the United States to spend high amounts of money on healthcare is an indication of readiness to do more including investing in unique medical tools such as ultrasonic scalpels.
This is through embracing minimally invasive surgeries, a relatively large population of geriatric demography to drive the surgery’s demand and the presence of a significant number of industry players in North America. Thus, measures on education and extensive training in healthcare settings bring about proper integration of state-of-the-art surgical technologies. Although North America continues to be a strong player, effective advancement and growth of this market intensely should take into consideration other regions like Europe and Asia-Pacific which may bring different factors to the increasing demand for ultrasonic scalpels.
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
The global ultrasonic scalpel market exhibits a dynamic competitive landscape influenced by factors such as technological advancements, regulatory compliance, and strategic market expansion. Key players like Ethicon Inc. (Johnson & Johnson), Olympus Corporation, and Medtronic plc maintain market dominance through a focus on product innovation, integrating ultrasonic technology with advanced features, and ensuring regulatory compliance. Companies engage in strategic collaborations and partnerships to expand their market presence and enhance accessibility.
Market expansion strategies include global outreach through mergers, acquisitions, and educational initiatives. Customer support and training programs are essential components, ensuring the effective and safe use of ultrasonic scalpel devices. The market is also susceptible to disruption from emerging players and start-ups introducing novel technologies. Continuous developments and shifts in the competitive landscape underscore the need for ongoing monitoring in this dynamic industry.
Some of the prominent players in the Global Ultrasonic Scalpel Market are
- Surgnova
- Johnson and Johnson
- Wuhan BBT Mini-Invasive Medical Tech. Co., Ltd.
- Axon Medical Solutions
- Olympus
- Bioventus LLC
- Medtronic PLC
- BOWA Medical UK
- Reach Surgical
- Industrial Design Consultancy Ltd
- Other Key Players
Recent Developments
- In June 2024, Johnson & Johnson launched the Harmonic HD 1000i, an advanced ultrasonic scalpel designed with an ergonomic handle and improved energy efficiency. This new product aims to reduce surgeon fatigue and enhance surgical precision.
- In April 2024, Medtronic entered into a strategic partnership with Mayo Clinic to provide comprehensive training programs for surgeons on the latest ultrasonic scalpel technologies. This collaboration aims to enhance the skill set of surgeons and improve surgical outcomes.
- In February 2024, Olympus Corporation received regulatory approval for its next-generation ultrasonic scalpel, the Thunderbeat Type S, featuring advanced coagulation capabilities and real-time feedback mechanisms to enhance surgical precision and safety.
- In October 2023, HistoSonics received FDA clearance for its Edison® Histotripsy System. The clearance makes Edison the first and only histotripsy platform available in the United States. FDA authorization was based on data from the HOPE4LIVER Trials, demonstrating safety and efficacy in treating liver tumors.
- In July 2023, the Heal Force UHS100 Ultrasonic Scalpel System is a newly launched product designed to revolutionize surgical methods that offer precision and efficiency through cutting-edge technology, providing surgeons with unparalleled control and accuracy during procedures.
- In June 2023, BOWA MEDICAL UK secured planning approval for a new UK headquarters in Kingskerswell, Devon. The 3-acre site will include a high-tech manufacturing plant, cleanroom, assembly, and machining facilities.
Report Details
| Report Characteristics |
| Market Size (2024) |
USD 2,397.6 Mn |
| Forecast Value (2033) |
USD 5,089 .1 Mn |
| CAGR (2024-2033) |
8.7% |
| Historical Data |
2018 – 2023 |
| The US Market Size (2024) |
USD 687.6 Mn |
| Forecast Data |
2025 – 2033 |
| Base Year |
2023 |
| Estimate Year |
2024 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Product (Ultrasonic Scalpel System, Ultrasonic Scalpel Accessories, and Ultrasonic Scalpel Generators), By Application (Orthopedic Surgery, Gynecological Surgery, Ophthalmic Surgery, Urological Surgery, Cardiovascular Surgery and Others), By End User (Hospitals, Ambulatory Surgery Centers and Specialty Clinics) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
Surgnova, Johnson and Johnson, Wuhan BBT Mini-Invasive Medical Tech. Co. Ltd., Axon Medical Solutions, Olympus, Bioventus LLC, Medtronic PLC, BOWA Medical UK, Reach Surgical, Industrial Design Consultancy Ltd, and Other Key Players |
| Purchase Options |
HVMN Inc., Thync Global Inc., Apple Inc., Fitbit Inc., TrackmyStack, OsteoStrong, The ODIN, Thriveport LLC, Muse, Moodmetric, and Other Key Players |
Frequently Asked Questions
The Global Ultrasonic Scalpels Market size is estimated to have a value of USD 2,397.6 million in 2024 and is expected to reach USD 5,089.1 million by the end of 2033.
The US Ultrasonic Scalpels Market size is anticipated to hold USD 687.6 million of the total global market revenue and is further projected to show this market concentration as it is projected to hold USD 1,394.2 million in 2033 at a CAGR of 8.2%.
North America has the largest market share for the Global Ultrasonic Scalpels Market with a share of about 34.1% in 2024.
Some of the major key players in the Global Ultrasonic Scalpels Market are Surgnova, Johnson and Johnson, and Wuhan BBT Mini-Invasive Medical Tech. Co., Ltd., and many others.
The market is growing at a CAGR of 8.7 percent over the forecasted period.